Taming the gatekeeper: ponatinib dose holds the key

Susan Branford^{1

2

3}

Affiliations

Free article

Editorial

Susan Branford. Blood. 2021.

Free article

. 2021 Nov 25;138(21):2011-2012.

doi: 10.1182/blood.2021013284.

Susan Branford^{1

2

3}

No abstract available

Comment on

Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial.
Cortes J, Apperley J, Lomaia E, Moiraghi B, Undurraga Sutton M, Pavlovsky C, Chuah C, Sacha T, Lipton JH, Schiffer CA, McCloskey J, Hochhaus A, Rousselot P, Rosti G, de Lavallade H, Turkina A, Rojas C, Arthur CK, Maness L, Talpaz M, Mauro M, Hall T, Lu V, Srivastava S, Deininger M. Cortes J, et al. Blood. 2021 Nov 25;138(21):2042-2050. doi: 10.1182/blood.2021012082. Blood. 2021. PMID: 34407543 Free PMC article. Clinical Trial.